TABLE 3.
NcRNAs | Name | Target Genes | Effect of Pyroptosis | Related Diseases | References |
---|---|---|---|---|---|
LncRNAs | lncRNA-Neat1 | caspase-1 | + | pneumonia | Zhang et al. (2019) |
lnc-LFAR1 | NLRP3 | + | liver fibrosis | Zhang. et al. (2020a) | |
lncRNA-NEXN-as 1 | NEXN | − | atherosclerosis | Wu et al. (2020) | |
lncRNA RP11-490M8.1 | TLR4/NF-κb | − | atherosclerosis | Liu et al. (2021a) | |
lncRNA-RP1-85F18.6 | GSDMD | − | colorectal cancer | Ma et al. (2018) | |
lncRNA AA388235 | caspase-3/GSDME | + | colorectal cancer | Chen et al. (2021a) | |
lncRNA-Fendrr | NLRC4 | + | diabetic brain I/R damage | Wang et al. (2021a) | |
MiRNAs | miR-141 | TXNIP/NLRP3 | + | intervertebral disk degeneration | Xu et al. (2020a) |
miR-148a | TXNIP | − | alcoholic liver disease | Heo et al. (2019) | |
miR-125b-2-3p | NLRP1 | − | hypoxic-ischemic encephalopathy | Huang et al. (2020) | |
miR-181b-5p | STAT-3 | − | atherosclerosis | Xu et al. (2021a) | |
miR-103 | BNIP3 | − | atherosclerosis | Wang et al. (2020b) | |
CircRNAs | hsa_circ_0001836 | NLRP1 | − | glioma | Liu et al. (2021b) |
circACTR2 | IL-1β | + | diabetic kidney disease | Wen et al. (2020) | |
circ_0029589 | NLRP3 | − | atherosclerosis | Guo et al. (2020a) | |
LncRNA-related ceRNA | lncRNA-H19/miR-21 | PDCD4 | + | retinal ischemia/reperfusion injury | Wen et al. (2020) |
lncRNA-F630028O10Rik/miR-1231-5P | Col1a1 | + | spinal cord injury | Xu et al. (2020b) | |
lncRNA-MEG3/miR-223 | NLRP3 | + | atherosclerosis | Zhang et al. (2018) | |
lncRNA MEG3/miR-485 | AIM2/caspase-1 | + | cerebral ischemia-reperfusion injury | Liang et al. (2020b) | |
lncRNA KCNQ1OT1/miR-214-3p | caspase-1 | + | diabetes cardiomyopathy | Yang et al. (2018b) | |
lncRNA KCNQ1OT1/miR-214 | caspase-1 | + | diabetic corneal endothelial keratopathy | Zhang et al. (2020b) | |
lncRNA ADAMTS9-AS2/miR-223-3p | NLRP3 | + | gastric cancer | Ren et al. (2020) | |
lncRNA GAS5/miR-452-5p | NLRP3/caspase-1 | − | diabetic nephropathy | Xie et al. (2019) | |
lncRNA ANRIL/miR-497 | TXNIP | + | diabetic nephropathy | Wang et al. (2021b) | |
lncRNA-HOTAIR/miR-22 | NLRP3 | + | hyperuricaemia | Chi et al. (2021) | |
lncRNA ORLNC1/miR-200b-3p | FOXO3 | + | osteoporosis | Zhang et al. (2021b) | |
CircRNA-related ceRNA | circ_0090231/miR-635 | NLRP3 | + | atherosclerosis | Ge et al. (2021) |
circHIPK3/miR-421 | NLRP3 | − | ischemic muscle injury | Yan et al. (2020) | |
circHIPK3/miR-193a-5p | GSDMD | + | acute pancreatitis | Wang et al. (2020b) | |
hsa_circ_0076631/miR-214-3p | caspase-1 | + | diabetic cardiomyopathy | Yang et al. (2019b) | |
circ-Calm4/miR-124-3p | PDCD6 | + | pulmonary hypertension | Jiang et al. (2021) |
+: pyroptosis promotion; −: pyroptosis inhibition.